{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:33:56Z","timestamp":1788176036271,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10072-021-05787-x","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T02:02:22Z","timestamp":1642989742000},"page":"3695-3701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Negative symptoms in Huntington\u2019s disease"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5043-0004","authenticated-orcid":false,"given":"Paola","family":"Soliveri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominga","family":"Paridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Del Sorbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Tramacere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriano","family":"Girotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"5787_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-71779-1_1","volume":"1049","author":"R Ghosh","year":"2018","unstructured":"Ghosh R, Tabrizi SJ (2018) Clinical features of Huntington\u2019s disease. Adv Exp Med Biol 1049:1\u201328. https:\/\/doi.org\/10.1007\/978-3-319-71779-1_1","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"5787_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/mds.23136","volume":"25","author":"N Reedeker","year":"2010","unstructured":"Reedeker N, Van Der Mast RC, Giltay EJ, Van Duijn E, Roos RAC (2010) Hypokinesia in Huntington\u2019s disease co-occurs with cognitive and global dysfunctioning. Mov Disord 25(11):612\u20131618. https:\/\/doi.org\/10.1002\/mds.23136","journal-title":"Mov Disord"},{"issue":"6","key":"5787_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/brainsci7060067","volume":"7","author":"RA Paoli","year":"2017","unstructured":"Paoli RA, Botturi A, Ciammola A, Silani V, Prunas C, Lucchiari C, Zugno E, Caletti E (2017) Neuropsychiatric burden in Huntington\u2019s disease. Brain Sci 7(6):67. https:\/\/doi.org\/10.3390\/brainsci7060067","journal-title":"Brain Sci"},{"key":"5787_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.02.008","volume":"25","author":"S Martinez-Horta","year":"2016","unstructured":"Martinez-Horta S, Perez-Perez J, van Duijn E, Fernandez-Bobadilla R, Carceller M, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Ruiz-Idiago J, Sampedro F, Landwehrmeyer GB, Spanish Registry Investigators of the European Huntington\u2019s Disease Network, Kulisevsky J (2016) Neuropsychiatric symptoms are very common in premanifest and early stage Huntington\u2019s disease. Parkinsonism Relat Disord 25:58\u201364. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.02.008","journal-title":"Parkinsonism Relat Disord"},{"key":"5787_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00415-006-7012-5","volume":"253","author":"R Levy","year":"2006","unstructured":"Levy R, Czernecki V (2006) Apathy and the basal ganglia. J Neurol 253:54\u201361. https:\/\/doi.org\/10.1007\/s00415-006-7012-5","journal-title":"J Neurol"},{"issue":"2","key":"5787_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.eurpsy.2008.09.001","volume":"24","author":"P Robert","year":"2009","unstructured":"Robert P, Onyike CU, Leentjens AFG, Dujardin K, Aalten P, Starkstein S, Verhey FRJ, Yessavage J, Clement JP, Drapier D, Bayle F, Benoit M, Boyer P, Lorca PM, Thibaut F, Gauthier S, Grossberg G, Vellas B, Byrne J (2009) Proposed diagnostic criteria for apathy in Alzheimer\u2019s disease and other neuropsychiatric disorders. Eur Psychiatry 24(2):98\u2013104. https:\/\/doi.org\/10.1016\/j.eurpsy.2008.09.001","journal-title":"Eur Psychiatry"},{"key":"5787_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.eurpsy.2018.07.008","volume":"54","author":"P Robert","year":"2018","unstructured":"Robert P, Lanct\u00f4t KL, Ag\u00fcera-Ortizc L, Aalten P, Bremond F, Defrancesco M, Hanon C, David R, Dubois B, Dujardin K, Husain M, K\u00f6nig A, Levy R, Mantua V, Meulien D, Miller D, Moebius HJ, Rasmussen J, Robert G, Ruthirakuhan M, Stella F, Yesavage J, Zeghari R, Manera V (2018) Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Eur Psychiatry 54:71\u201376. https:\/\/doi.org\/10.1016\/j.eurpsy.2018.07.008","journal-title":"Eur Psychiatry"},{"key":"5787_CR8","first-page":"1432","volume-title":"Kaplan & Sadock\u2019s comprehensive textbook of psychiatry","author":"CA Tamminga","year":"2009","unstructured":"Tamminga CA (2009) Schizophrenia and other psychotic disorders. In: Sadock BJ, Sadock VA, Ruiz P, Kaplan HI (eds) Kaplan & Sadock\u2019s comprehensive textbook of psychiatry, 9th edn. Wolters Kluwer Health\/Lippincott Williams & Wilkins, Philadelphia, pp 1432\u20131628","edition":"9"},{"key":"5787_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00406-015-0590-4","volume":"265","author":"S Galderisi","year":"2015","unstructured":"Galderisi S, Merlotti E, Mucci A (2015) Neurobiological background of negative symptoms. Eur Arch Psychiatry Clin Neurosci 265:543\u2013558. https:\/\/doi.org\/10.1007\/s00406-015-0590-4","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"5787_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.schres.2015.10.036","volume":"169","author":"DA Schlosser","year":"2015","unstructured":"Schlosser DA, Campellone TR, Biagianti B, Delucchi KL, Gard DE, Fulford D, Stuart BK, Fisher M, Loewy RL, Vinogradov S (2015) Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis. Schizophr Res 169:204\u2013208. https:\/\/doi.org\/10.1016\/j.schres.2015.10.036","journal-title":"Schizophr Res"},{"issue":"7","key":"5787_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.4103\/1119-3077.212453","volume":"20","author":"S Oru\u04ab","year":"2017","unstructured":"Oru\u04ab S, G\u00fclseren G, Kusbeci OY, \u04e6zbulut O (2017) An evaluation of neuropsychiatric symptoms in Parkinson\u2019s disease patients. Niger J Clin Pract 20(7):900\u2013904. https:\/\/doi.org\/10.4103\/1119-3077.212453","journal-title":"Niger J Clin Pract"},{"issue":"2","key":"5787_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/schbul\/sbj053","volume":"32","author":"B Kirkpatrick","year":"2006","unstructured":"Kirkpatrick B, Fenton WS, Carpenter WT Jr, Marder SR (2006) The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 32(2):214\u2013219. https:\/\/doi.org\/10.1093\/schbul\/sbj053","journal-title":"Schizophr Bull"},{"key":"5787_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/wps.20385","volume":"16","author":"SR Marder","year":"2017","unstructured":"Marder SR, Galderisi S (2017) The current conceptualization of negative symptoms in schizophrenia. World Psychiatry 16:14\u201324. https:\/\/doi.org\/10.1002\/wps.20385","journal-title":"World Psychiatry"},{"issue":"3","key":"5787_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/mdc3.13147","volume":"8","author":"KJ Atkins","year":"2021","unstructured":"Atkins KJ, Andrews SC, Chong TT-J, Stout JC (2021) Multidimensional apathy: the utility of the dimensional apathy scale in Huntington\u2019s disease. Mov Disord Clin Pract 8(3):361\u2013370. https:\/\/doi.org\/10.1002\/mdc3.13147","journal-title":"Mov Disord Clin Pract"},{"key":"5787_CR15","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.nicl.2019.101965","volume":"24","author":"AE De Paepe","year":"2019","unstructured":"De Paepe AE, Sierpowska J, Garcia-Gorro C, Martinez-Horta S, Perez-Perez J, Kulisevsky J, Rodriguez-Dechicha N, Vaquer I, Subira S, Calopa M, Mu\u00f1oz E, Santacruz P, Ruiz-Idiago R, Mareca C, de Diego-Balaguer R, Camara E (2019) White matter cortico-striatal tracts predict apathy subtypes in Huntington\u2019s disease. NeuroImage: Clinical 24:101965. https:\/\/doi.org\/10.1016\/j.nicl.2019.101965","journal-title":"NeuroImage: Clinical"},{"key":"5787_CR16","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","volume":"85","author":"E van Duijn","year":"2014","unstructured":"van Duijn E, Craufurd D, Hubers AAM, Giltay EJ, Bonelli R, Rickards H, Anderson KE, van Walsem MR, van der Mast RC, Orth M, Landwehrmeyer GM, the European Huntington\u2019s Disease Network Behavioural Phenotype Working Group (2014) Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry 85:1411\u20131418. https:\/\/doi.org\/10.1136\/jnnp-2013-307343","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5787_CR17","volume-title":"The Scale for the Assessment of Negative Symptoms (SANS)","author":"NC Andreasen","year":"1983","unstructured":"Andreasen NC (1983) The Scale for the Assessment of Negative Symptoms (SANS). The University of Iowa, Iowa City, Iowa"},{"key":"5787_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1192\/S0007125000291496","volume":"7","author":"NC Andreasen","year":"1989","unstructured":"Andreasen NC (1989) The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl 7:49\u201358","journal-title":"Br J Psychiatry Suppl"},{"key":"5787_CR19","volume-title":"The Scale for the Assessment of Positive Symptoms (SAPS)","author":"NC Andreasen","year":"1984","unstructured":"Andreasen NC (1984) The Scale for the Assessment of Positive Symptoms (SAPS). The University of Iowa, Iowa City, Iowa"},{"issue":"12","key":"5787_CR20","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1176\/ajp.144.12.1595","volume":"144","author":"M Moscarelli","year":"1987","unstructured":"Moscarelli M, Maffei C, Cesana BM, Boato P, Farma T, Grilli A, Lingiardi V, Cazzullo CL (1987) An international perspective on assessment of negative and positive symptoms in schizophrenia. Am J Psychiatry 144(12):1595\u20131598. https:\/\/doi.org\/10.1176\/ajp.144.12.1595","journal-title":"Am J Psychiatry"},{"key":"5787_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.29.1.1","volume":"29","author":"I Shoulson","year":"1979","unstructured":"Shoulson I, Fahn S (1979) Huntington disease: clinical care and evaluation. Neurology 29:1\u20133","journal-title":"Neurology"},{"key":"5787_CR22","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn, Text revision (DSM-IV-TR), Washington DC"},{"issue":"2","key":"5787_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Huntington\u2019s Disease Rating Scale: reliability and consistency. Mov Disord 11(2):136\u2013142. https:\/\/doi.org\/10.1002\/mds.870110204","journal-title":"Mov Disord"},{"key":"5787_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"issue":"2","key":"5787_CR25","first-page":"278","volume":"47","author":"G Novelli","year":"1986","unstructured":"Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G (1986) Tre test clinici di memoria verbale a lungo termine. Taratura su soggetti normali. Archivio di Psicologia Neurologia e Psichiatria 47(2):278\u2013296","journal-title":"Archivio di Psicologia Neurologia e Psichiatria"},{"issue":"4","key":"5787_CR26","first-page":"477","volume":"47","author":"G Novelli","year":"1986","unstructured":"Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G (1986) Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Archivio di Psicologia Neurologia e Psichiatria 47(4):477\u2013506","journal-title":"Archivio di Psicologia Neurologia e Psichiatria"},{"key":"5787_CR27","first-page":"1","volume":"8","author":"H Spinnler","year":"1987","unstructured":"Spinnler H, Tognoni G (1987) Gruppo italiano per lo studio neuropsicologico dell\u2019invecchiamento. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci Suppl 8:1\u2013120","journal-title":"Ital J Neurol Sci Suppl"},{"key":"5787_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50\u201355","journal-title":"Br J Med Psychol"},{"key":"5787_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5787_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","volume":"24","author":"JC Thompson","year":"2012","unstructured":"Thompson JC, Harris J, Sollom AC, Stopford CL, Howard E, Snowden JS, Craufurd D (2012) Longitudinal evaluation of neuropsychiatric symptoms in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 24:53\u201360. https:\/\/doi.org\/10.1176\/appi.neuropsych.11030057","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"5787_CR31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000091523","volume":"21","author":"S Baudic","year":"2006","unstructured":"Baudic S, Maison P, Dolbeau G, Boiss\u00e9 M-F, Bartolomeo P, DallaBarba G, Traykov L, Bachoud-L\u00e9vi A-C (2006) Cognitive impairment related to apathy in early Huntington\u2019s disease. Dement Geriatr Cogn Disord 21:316\u2013321. https:\/\/doi.org\/10.1159\/000091523","journal-title":"Dement Geriatr Cogn Disord"},{"key":"5787_CR32","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/NMD.0000000000000190","volume":"202","author":"G Cipriani","year":"2014","unstructured":"Cipriani G, Lucetti C, Danti S, Nuti A (2014) Apathy and dementia. Nosology, assessment and management. J Nerv Ment Dis 202:718\u2013724. https:\/\/doi.org\/10.1097\/NMD.0000000000000190","journal-title":"J Nerv Ment Dis"},{"issue":"2","key":"5787_CR33","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/schbul\/sbj011","volume":"32","author":"PD Harvey","year":"2006","unstructured":"Harvey PD, Koren D, Reichenberg A, Bowie CR (2006) Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull 32(2):250\u2013258. https:\/\/doi.org\/10.1093\/schbul\/sbj011","journal-title":"Schizophr Bull"},{"key":"5787_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/978-3-642-76841-5_11","volume-title":"Negative versus positive schizophrenia","author":"K Maurer","year":"1991","unstructured":"Maurer K, H\u00e4fner H (1991) Dependence, independence or interdependence of positive and negative symptoms. In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia. Springer-Verlag, Berlin Heidelberg, pp 160\u2013182"},{"key":"5787_CR35","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/s0028-3932(02)00221-x","volume":"4","author":"JS Snowden","year":"2003","unstructured":"Snowden JS, Gibbons ZC, Blackshaw A, Doubleday E, Thomson J, Craufurd D, Foster J, Happ\u00e9 F, Neary D (2003) Social cognition in frontotemporal dementia and Huntington\u2019s disease. Neuropsychologia 4:688\u2013701. https:\/\/doi.org\/10.1016\/s0028-3932(02)00221-x","journal-title":"Neuropsychologia"},{"issue":"4","key":"5787_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/mds.23494","volume":"26","author":"M Br\u00fcne","year":"2011","unstructured":"Br\u00fcne M, Blank K, Witthaus H, Saft C (2011) \u201cTheory of mind\u201d is impaired in Huntington\u2019s disease. Mov Disord 26(4):671\u2013678. https:\/\/doi.org\/10.1002\/mds.23494","journal-title":"Mov Disord"},{"key":"5787_CR37","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuint.2019.05.001","volume":"128","author":"E Puginier","year":"2019","unstructured":"Puginier E, Bharatiya R, Chagraouic A, Manema J, Choa YH, Garreta M, De Deurwaerd\u00e8re P (2019) Early neurochemical modifications of monoaminergic systems in the R6\/1 mouse model of Huntington\u2019s disease. Neurochem Int 128:186\u2013195. https:\/\/doi.org\/10.1016\/j.neuint.2019.05.001","journal-title":"Neurochem Int"},{"key":"5787_CR38","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1176\/appi.ajp.162.4.725","volume":"162","author":"JS Paulsen","year":"2005","unstructured":"Paulsen JS, FerneyhoughHoth K, Nehl C, Stierman L (2005) Critical periods of suicide risk in Huntington\u2019s disease. Am J Psychiatry 162:725\u2013731. https:\/\/doi.org\/10.1176\/appi.ajp.162.4.725","journal-title":"Am J Psychiatry"},{"key":"5787_CR39","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/gps.2284","volume":"24","author":"LC Emmerson","year":"2009","unstructured":"Emmerson LC, Ben-Zeev D, Granholm E, Tiffany M, Golshan S, Jeste DV (2009) Prevalence and longitudinal stability of negative symptoms in healthy participants. Int J Geriatr Psychiatry 24:1438\u20131444. https:\/\/doi.org\/10.1002\/gps.2284","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"5787_CR40","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/mds.27395","volume":"33","author":"S Mart\u00ednez-Horta","year":"2018","unstructured":"Mart\u00ednez-Horta S, Sampedro F, Pagonabarraga J, Horta-Barba A, Carceller-Sindreu M, Gomez-Anson B, Lozano-Martinez GA, Lopez-Mora DA, Camacho V, Fern\u00e1ndez-Le\u00f3n A, Carri\u00f3 I, Kulisevsky J (2018) Structural and metabolic brain correlates of apathy in Huntington\u2019s disease. Mov Disord 33(7):1151\u20131159. https:\/\/doi.org\/10.1002\/mds.27395","journal-title":"Mov Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05787-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05787-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05787-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T03:48:11Z","timestamp":1653018491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05787-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5787"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05787-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"27 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Besta ethical committee (EC Number 7\/04, 2014).\u00a0All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}